Regulation 3
1. The manufacturer shall provide and maintain such staff, premises, and plant as are necessary for the carrying out in accordance with the relevant product licences of such stages of the manufacture and assembly of the medicinal products to which the relevant product licences relate as are undertaken by him.
2. The manufacturer shall provide and maintain such staff, premises, equipment and facilities for the handling, storage and distribution of the medicinal products to which the relevant product licences relate which he handles, stores or distributes as are necessary to avoid deterioration of the medicinal products.
3. The manufacturer shall conduct all manufacture and assembly operations in such a way as to ensure that the medicinal products to which the relevant product licenses relate conform with the standards of strength, quality and purity applicable to them under the relevant product licences.
4. Where animals are used in the production of any medicinal product and the relevant product licences contain provisions relating to them the manufacturer shall arrange for the animals to be housed in premises of such a nature and to be managed in such a way as will facilitate compliance with such provisions.
5. The manufacturer shall make such adequate and suitable arrangements as are necessary for carrying out in accordance with the relevant product licences any tests of the strength, quality or purity of the medicinal products to which the licences relate.
6. The manufacturer shall inform the holder of the relevant product licences of any material alteration in the premises or plant used in connection with the manufacture or assembly of the medicinal products to which the relevant product licences relate or in the operations for which such premises or plant are so used and of any change, since the granting of the relevant product licences in respect of any person—
(a)responsible for supervising the production operations, or
(b)responsible for quality control of the medicinal products to which the relevant product licences relate, or
(c)in charge of the animals from which are derived any substance used in the production of the medicinal products to which the relevant product licences relate, or
(d)responsible for the culture of any living tissues used in the manufacture of the medicinal products to which the relevant product licences relate.
7. The manufacturer shall keep readily available for inspection by a person authorised by the licensing authority durable records of the details of manufacture and assembly of each batch of every medicinal product to which each relevant product licence relates and of the tests carried out thereon in such a form that the records will be easily identifiable from the number of the batch as shown on each container in which the medicinal product is exported from the country where it has been manufactured or assembled; the manufacturer shall permit the person authorised to take copies of or make extracts from such records. Such records shall not be destroyed for a period of five years from the date when the manufacture or assembly of the relevant batch of the medicinal product occurred.
8. The manufacturer shall inform the holder of the relevant product licence of any material change since the date upon which such licence was granted in respect of—
(a)the facilities and equipment available at each of the premises of the manufacturer for carrying out any stage of the manufacturer or assembly of the medicinal products to which the relevant product licences relate, or
(b)the facilities and equipment available in each of the premises of the manufacturer for the storage of the medicinal products to which the relevant product licences relate on, and distribution of the products from or between, such premises, or
(c)any manufacturing operations, not being operations in relation to the medicinal products to which the relevant product licences relate, which are carried on by the manufacturer on or near any of the premises on which such medicinal products are manufactured or assembled and the substances or articles in respect of which such operations are carried on, or
(d)the arrangements for the identification and storage of materials and ingredients before and during manufacture of the medicinal products to which the relevant product licences relate and the arrangements for the storage of the medicinal products after they have been manufactured or assembled, or
(e)the arrangements for ensuring a satisfactory turnover of stocks of medicinal products to which the relevant product licences relate, or
(f)the arrangements for maintaining production records and records of analytical and other testing procedures applied in the course of manufacture or assembly of the medicinal products to which the relevant product licences relate, or
(g)the arrangements for keeping reference samples of materials used in the manufacture of any medicinal products to which the relevant product licences relate and reference samples of such medicinal products.